Perioperative Multidisciplinary Therapy for Technically Resectable Hepatocellular Carcinoma With Vein Thrombosis: An Exploratory Clinical Trail
Latest Information Update: 14 Jan 2022
Price :
$35 *
At a glance
- Drugs Sintilimab (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 21 Dec 2021 Status changed from recruiting to discontinued.
- 10 Dec 2020 New trial record